CN Patent

CN113413387A — 治疗炎症或神经性疼痛的方法

Assigned to H Lundbeck AS · Expires 2021-09-21 · 5y expired

What this patent protects

本申请涉及治疗炎症或神经性疼痛的方法。本文提供了使用有效剂量的单酰基甘油脂肪酶抑制剂或其组合物治疗炎症或神经性疼痛的方法。尤其，本申请涉及有效剂量的4‑(2‑(吡咯烷‑1‑基)‑4‑(三氟甲基)苄基)哌嗪‑1‑甲酸1,1,1,3,3,3‑六氟丙烷‑2‑基酯或其药学上可接受的盐在制备用于治疗有需要的患者的炎症或神经性疼痛的药物中的应用，其中所述有效剂量为1mg至500mg。

USPTO Abstract

本申请涉及治疗炎症或神经性疼痛的方法。本文提供了使用有效剂量的单酰基甘油脂肪酶抑制剂或其组合物治疗炎症或神经性疼痛的方法。尤其，本申请涉及有效剂量的4‑(2‑(吡咯烷‑1‑基)‑4‑(三氟甲基)苄基)哌嗪‑1‑甲酸1,1,1,3,3,3‑六氟丙烷‑2‑基酯或其药学上可接受的盐在制备用于治疗有需要的患者的炎症或神经性疼痛的药物中的应用，其中所述有效剂量为1mg至500mg。

Drugs covered by this patent

Patent Metadata

Patent number
CN113413387A
Jurisdiction
CN
Classification
—
Expires
2021-09-21
Drug substance claim
No
Drug product claim
No
Assignee
H Lundbeck AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.